The elucidation of chronic inflammation by IL-23/Th17 and the application to cancer immunotherapy
| Project/Area Number |
23791482
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
MATSUSHITA Marimo (SATO Marimo) 東京大学, 医科学研究所, 助教 (50401253)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 実験外科学 / IL-23 / Th17 / IL-17 / 癌免疫療法 / 慢性炎症 / 抗腫瘍効果 |
|---|
| Research Abstract |
Th1 cells and Th17 cells were significantly enhanced by systemic administration of IL-23. However, it is still unknown about the effects of Th17 cells in antitumor immunity. Th17 cells promote an IL-17 production through IL-23 which a macrophage and dendritic cells produce by antigen stimulation in chronic inflammation. In this project, I have found the mechanisms of the antitumor effects of Th17 cells by systemicadministration of IL-23 using wild-type and IL-17 knockout mouse.
|
Report
(3 results)
Research Products
(11 results)
